Is Alnylam Pharmaceuticals, Inc. overvalued?

Alnylam Pharmaceuticals, Inc. (ALNY) — key valuation metrics and fundamentals.

No verdict

Price

$223.95

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$29.97B

Dividend yield

0.0%

Return on equity

93.6%

Sector

Healthcare

Fair value compares ALNY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks